A nursing professor dispels common myths, explains the risks, and highlights promising new treatments. Breast cancer is one of the most commonly diagnosed cancers in the world and remains a major cause of cancer-related illness in the…
The actress was diagnosed with luminal B cancer, an 'aggressive, fast-moving' disease, in 2023 and has since shared her journey. Find out more about her health here.
Jessie J didn't let the blustery weather dampen her spirits as she beamed while her dark locks were blown around on the red carpet at the Royal Variety Performance on Wednesday night.
News Ghana, Latest Updates and Breaking News of Ghana, AMA, https://www.newsghana.com.gh/zimbabwe-strengthens-integrated-cancer-services-to-improve-womens-health/Zimbabwe is intensifying efforts to improve the prevention, early detection…
Exclusive: New federal guidelines advise GPs to provide additional care to patients with higher breast density, which can make cancers harder to detect in mammograms
Veterans with male breast cancer will face additional requirements to obtain VA care and disability benefits. The agency says the Biden Administration falsely classified men's breasts as reproductive organs.
Get latest articles and stories on Business at LatestLY. Bengaluru (Karnataka) [India], November 19: Pinkathon, India's biggest women's run, has joined hands with global innovation-led healthcare company Zydus Lifesciences Ltd. in a…
When fashion model Christine Handy was diagnosed with breast cancer at 41, she turned to movies for answers. What she found on screen instead were glossy fantasies that didn’t properly depict her reality. “What I found was troubling and…
A research team led by two University of Maine Ph.D. students developed an artificial intelligence (AI) system that could make it easier and faster for doctors to identify signs of breast cancer in tissue samples, possibly preventing…
Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.
(MedPage Today) -- The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is becoming increasingly complex, with decisions now shaped by ESR1 and PIK3CA mutations, CDK4/6…